FindTrial
Sign In

Hepcidin kinetics in hemodialysis patients.

Hepcidin kinetics in hemodialysis patients. - Hepcidin and hemodialysis.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34512
Enrollment
40
Registered
2010-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemodialysis treatment with artificial kidney

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult hemodialysis patients (>18 yrs) hemodialysis for at least 4 months no IV iron or EPO during experimental dialysis sessions

Exclusion criteria

Exclusion criteria: malignancies/ overt infection/ hepatic failure, gastro-intestinal bleeding and blood transfusion during the preceding 4 months no informed consent

Design outcomes

Primary

MeasureTime frame
Serum and dialysate hepcidin-25 and its two smaller isoforms hepcidin-22 and 20.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)